tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - carcinoma, pulmón no microcítico - agentes antineoplásicos - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
tadamax 20 láminas bucodispersables 20 mg (tadalafilo)
megalabs chile s.a. - tadalafilo - sin formulas
agil
adama - concentrado emulsionable (ec) - propaquizafop 10% p/v (100 g/l) - control de malas hierbas
goltix 700 sc
adama - suspensión concentrada (sc) - metamitrona 70% p/v (700 g/l) - control de malas hierbas
kona
adama - suspensión concentrada (sc) - mandipropamid 25% p/v - control de enfermedades
cottonex neopro
adama - suspensión concentrada (sc) - fluometuron 25% + terbutilazina 20,8% - control de malas hierbas
custodia
adama - suspensión concentrada (sc) - azoxistrobin 12% p/v (120g/l) + tebuconazol 20% p/v (200g/l) - control de enfermedades
elegant
adama - suspo-emulsión (se) - florasulam 6,25 g/l + 2,4-d 300 g/l. - control de malas hierbas
klartan ew
adama - emulsión oleosa en agua (ew) - tau-fluvalinato 24% (p/v) - control de plagas
legacy plus
adama - suspensión concentrada (sc) - clortoluron 40%p/v (400g/l) + diflufenican 2,5%p/v (25g/l) - control de malas hierbas